Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06152497

The Role of Histamine in Muscle Protein Synthesis Following Resistance Training

The Role of Histamine in Muscle Protein Synthesis Following Chronic Resistance Training

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Ghent · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Blocking histamine H1/H2 receptors blunts chronic endurance training adaptations. The current study addresses the following research question: "What is the influence of histamine H1 signaling on training adaptations following ten weeks of resistance training in human skeletal muscle." Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboOral placebo
DRUGH1 blockade: Telfast: 180mg FexofenadineH1 blockade: oral blockade with 180mg Fexofenadine
BEHAVIORALResistance trainingResistance training: lower body exercise

Timeline

Start date
2023-09-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2023-11-30
Last updated
2023-12-13

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06152497. Inclusion in this directory is not an endorsement.

The Role of Histamine in Muscle Protein Synthesis Following Resistance Training (NCT06152497) · Clinical Trials Directory